about CT scans and radiation exposure in children and young people. Unable to find your location. The following are some examples of common screening tests: Cholesterol is a waxy substance that can be found in all parts of the body. Box 9010, Stuart, FL 34995, Notice of Non-Discrimination & Accessibility, Cleveland Clinic Martin Health on social media, Physician and Advance Practice Provider Careers. During a colonoscopy, a tube is inserted into the anus to view the inside of the large bowel. Sometimes the fluids analyzed are present only if a disorder is present, as when fluid collects in the abdomen, causing ascites, or in the space between the two-layered membrane covering the lungs and lining the chest wall (pleura), causing pleural effusion. Tissues that are commonly examined include skin, breast, lung, liver, kidney, and bone. Read more on Diagnostic Imaging Pathways website, Why and when to get tested for total protein. Find out what the scan involves and how it works. Visit the Martin Health System Laboratory Resource Directory for Laboratory Information, Specimen Collection Information, Laboratory Forms and more. The lungs ability to hold air, to move air in and out, and to exchange oxygen and carbon dioxide is measured with pulmonary function tests. Corrections? 2018 Dr Lal PathLabs. Many organizations, including the USPSTF, recommend mammography screening for breast cancer every 1 year to 2 years after age 50. See additional information. connection to land, sea and community. You may need to fast for up to 12 hours before this test. rsv alaskan native natives alaska cdc UrinalysisOften the first lab test performed, this is a general screening test used to check for early signs of disease. All Right Reserved. To find out how well your heart is working, your doctor may ask you to have an electrocardiogram (ECG). Such incisions are used to view the inside of the following: Area of the chest between the lungs (mediastinoscopy). This blood test measures the prostate specific antigen (PSA) levels in the blood. For example, electrical activity of the heart is measured with electrocardiography (ECG), and electrical activity of the brain is measured with electroencephalography (EEG). to the content webpage. Please click here for Visitation Guidelines. URL of this page: https://medlineplus.gov/lab-tests/. Select a symptom, answer some questions, get advice. Explore our network of care for kids, from the tiniest to teens and young adults. However, sometimes an opening in the body must be created. Your email is invalid. The cervical screening test is a safe, quick test carried out by a health professional. It is important to understand, however, that people can still have heart disease even with cholesterol levels in the normal range. Brought to you by Merck & Co, Inc., Rahway, NJ, USA (known as MSD outside the US and Canada)dedicated to using leading-edge science to save and improve lives around the world. Normal test values are expressed as a range, which is based on the average values in a healthy population. A medication interaction is defined as a measurable modification (in magnitude and/or duration) of the action of one medicine, by prior or concomitant administration of another substance, including prescription, non-prescription medicines, food, alcohol, cigarette smoking or diagnostic tests. Please confirm that you are not located inside the Russian Federation. It measures the types and numbers of cells in the blood, including red and white blood cells and platelets. ennis banish ghosts hypo athletics Read more on ACI - Agency for Clinical Innovation website, A colonoscopy is a diagnostic test to look inside your large bowel. steve scammer scammers profile The Pap smear is an important screening test in sexually active women under the age of 65, to detect cancer at a stage when there are often no symptoms. Antigens are any substances that evoke responses from a person's immune system. However, some screening tests, when used in people not at high risk for disease, or when testing for very rare diseases, can cause more problems than they help. Every test has some risk. Read more on Pregnancy, Birth & Baby website. For some tests, these values also vary among laboratories. These tests provide a picture of the inside of the bodyin its entirety or only of certain parts ( see Overview of Imaging Tests Overview of Imaging Tests Imaging tests provide a picture of the bodys interiorof the whole body or part of it. Find out what happens and the preparation you will have to complete for this test, Read more on Cancer Council Australia website. can help detect a condition, determine a diagnosis, plan treatment, check to Masks are required inside all of our care facilities, COVID-19 testing locations on Maryland.gov, Ciccarone Center for the Prevention of Heart Disease. The Basic Metabolic Panel can help your doctor monitor the effects of medications you are taking, such as high blood pressure medicines, can help diagnose certain conditions, or can be part of a routine health screening. Please check and try again. The trusted provider of medical information since 1899, Last full review/revision Mar 2010| Content last modified Jan 2020. (See alsoddiagnosis; medicine; pathology.). The prostate specific antigen levels can be elevated in the presence of prostate cancer. MedicineNet does not provide medical advice, diagnosis or treatment. For example, endoscopy of the stomach enables the examiner to view the inside of the stomach as well as obtain tissue samples for examination in a laboratory. It is important to understand that when blood is present in a stool sample, it can be due to other noncancerous factors, such as certain medications or foods, gastrointestinal bleeding, or hemorrhoids. healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do. The goal is early detection and lifestyle changes or surveillance, to reduce the risk of disease, or to detect it early enough to treat it most effectively. Why, when and how to get a cervical screening test. This coagulation test measures the presence and activity of five different blood clotting factors. Terms of Use. Tissue samples are removed and examined, usually with a microscope. Doctors weigh the risk of a test against the usefulness of the information it will provide. Clinical Chemistry and Biochemical Genetics, Microbiology, Serology & Clinical Pathology, Histocompatibility & Transplant Immunology, Role of Immunohistochemistry in diagnosis of solid tumors, Next-Generation Sequencing (NGS) & its application in Precision Medicine for Cancer. Cleveland Clinic Florida region hospitals are at Level Yellow. Extraordinary kid care Consult your healthcare provider regarding all of these as well as other types of screening tests, based on your medical condition, as not all healthcare providers are in agreement in regard to which screening tests should be done and for which age groups. Sometimes a disorder can be treated at the same time a screening or diagnostic test is done. The same test may be repeated after treatment to determine whether the number of red blood cells has returned to normal. Read more on Consumers Health Forum of Australia website, The word "X-ray" or "scan" will often be used by the doctor while talking about a test or treatment for your child, Read more on Sydney Children's Hospitals Network website. Medical problem? Please enter a suburb or postcode of your location and select from the list. Be sure to consult your healthcare provider regarding the appropriate timing and frequency of all screening tests based on your age, overall health, and medical history. Accommodations. We are a government-funded service, providing quality, approved health information and advice. We're ranked #1 in pediatric cancer, heart surgery, cardiology & more. information. Masks are required inside all of our care facilities. 
Disease articles are written by U.S. Board Certified Physicians. This page aggregates information that directly links to Pathology Tests Explained. However, the liver produces all of the cholesterol the body needs. Could a Common Diabetes Drug Ease Bipolar Disorder. This information is for people who want to find out more about why they have been asked to have a diagnostic test and what it could involve so that they can make an informed choice about it. 200 SE Hospital Ave. That is, 95% of healthy people have values within this range. While every effort has been made to follow citation style rules, there may be some discrepancies. These tests are usually performed in a consulting room by any doctor and require no advanced equipment. recent indian singh march india does programme under national swachh launched A blood test may show that a person has too few red blood cells (anemia). 'On Edge': Anxious Americans Line Up for Scarce Monkeypox Vaccines, Alternative Medicine Popular Among Seniors, But Most Don't Tell Their Doctors About It, Biden Tests Negative for COVID, Ends Isolation Period. Comprehensive Metabolic PanelThis test combines the Basic Metabolic Panel with six more tests for a more comprehensive evaluation of metabolic functions, with a focus on organ systems. Alpha Fetoprotein (AFP) Tumor Marker Test, Antineutrophil Cytoplasmic Antibodies (ANCA) Test, Beta 2 Microglobulin (B2M) Tumor Marker Test, Bronchoscopy and Bronchoalveolar Lavage (BAL), Developmental and Behavioral Screening Tests, Electromyography (EMG) and Nerve Conduction Studies, Estrogen Receptor, Progesterone Receptor Tests, Fetal Alcohol Spectrum Disorders (FASD) Screening, Follicle-Stimulating Hormone (FSH) Levels Test, IGF-1 (Insulin-like Growth Factor 1) Test, Lactate Dehydrogenase (LDH) Isoenzymes Test, Natriuretic Peptide Tests (BNP, NT-proBNP), Total Protein and Albumin/Globulin (A/G) Ratio, What You Need to Know About Blood Testing, U.S. Department of Health and Human Services. We pay our respects to the Traditional Owners and to Elders both past and Abdominoplasty (Tummy Tuck ( Abdominoplasty)), Ablation, Endometrial (Endometrial Ablation), Abnormal Liver Enzymes (Liver Blood Tests), Absorbent Products Incontinence (Urinary Incontinence Products for Men), Abstinence Method of Birth Control (Natural Methods of Birth Control), Adenosine Stress Test For Heart Disease (Coronary Artery Disease Screening Tests (CAD)), AFP Blood Test (Alpha-fetoprotein Blood Test), Alexander Technique for Childbirth (Childbirth Class Options), Allergy, Skin Test (Skin Test For Allergy), Annulus Support (Heart Valve Disease Treatment), Anti-citrulline Antibody (Citrulline Antibody), Anti-cyclic Citrullinated Peptide Antibody (Citrulline Antibody), Antibiotic Prophylactic Regimens for Endocarditis, Antimicrosomal Antibody Test (Thyroid Peroxidase Test), Antithyroid Microsomal Antibody Test (Thyroid Peroxidase Test), Aortic Heart Valve Replacement (Heart Valve Disease Treatment), Appendectomy recovery complications prognosis, Arrhythmia Treatment (Ablation Therapy for Arrhythmias), Arthritis Physical and Occupational Therapy, Arthroplasty (Joint Replacement Surgery Of The Hand), Auditory Brainstem Response (Newborn Infant Hearing Screening). We've got you covered. bsi thucydides asks tantalus enormous 
If you need urgent medical help, call triple zero immediately. Regular eye tests can pick up problems before you notice any symptoms and you dont need a referral to see an optometrist. This test is done in conjunction with a clinical breast exam, Many organizations, including the USPSTF, recommend screening for colon cancer or colon polyps at age 50, earlier if you have a family history or other risk factors. We currently support Microsoft Edge, Chrome, Firefox and Safari. P.O. A viewing tube (endoscope) is used to directly observe the inside of body organs or spaces (cavities). Copyright 2022 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. Free Australian health advice you can count on. Find out about the screening and diagnostic tests that can detect the condition. InsideRadiology provides free and easily accessible, accurate, up to date and credible information about medical imaging tests and procedures. Liver PanelThe liver panel is a combination of tests used to assess liver function and establish the possible presence of liver tumors. The tip of the endoscope is usually equipped with a light and a camera, so the examiner watches the images on a television monitor rather than looking directly through the endoscope. Terms of Service apply. Testing is recommended starting at age 50 by many organizations including the American Cancer Society. Find out whats involved. Tests are usually one of the six following types. While screening tests are not 100% accurate in all cases, it is generally more valuable to have the screening tests at the appropriate times, as recommended by your healthcare provider, than to not have them at all. Tradition Pharmacy Martin Health Physician Group New Patient Information Form (MHPG) Cancer Services Neurosciences Fitness Centers Wellness Support Services Community Benefit Compliance and Privacy , 772.287.5200 At Another Johns Hopkins Member Hospital: Mammograms and More: Breast Cancer Screening Guidelines, Virtual Colonoscopy Screening to Combat Colon Cancer. Studies have shown that people with high cholesterol can reduce their risk for heart disease by lowering their cholesterol. There are different types of medical tests but the lines that separate them often become blurred. Best in Northern CA Learn about medical tests, including what the tests are A biopsy helps a doctor diagnose a medical condition. It includes cholesterol and triglyceride levels. Our specialists handle conditions ranging from the common to the most rare. 
Screening tests are not considered diagnostic, but are used to identify a subset of the population who should have additional testing to determine the presence or absence of disease. Please enter manually below. Lipid PanelThe lipid panel is a group of tests used to evaluate cardiac risk. Terms of Use. Looks like youre visiting Benioff Children's Hospitals on Internet Explorer. Sometimes a test is used for more than one purpose. For more information, see www.labtestsonline.org, a public resource on clinical laboratory testing. Some of the cons include unnecessary testing and procedures, unnecessary costs, and significantly increased anxiety. Additionally, individuals without symptoms of diabetes should be screened if they are overweight or obese and have one or more additional diabetes risk factors. The pros and cons of PSA screening should always be discussed with your healthcare provider before testing. It is grouped by type of procedure and ordered alphabetically. This pathway provides guidance on the staging of adult patients with renal carcinoma confirmed by biopsy or previous imaging. The test is a simple procedure to check the health of a persons cervix, it is expected to protect up to 30% more people than the pap smear was able to. An MRI scanner uses strong magnetic fields, radio waves and a computer to take pictures of the soft tissue inside of your body. Fecal occult blood is detected by microscopic analysis or by chemical tests for hemoglobin (blood) in the stool. It aids in the production of cell membranes, some hormones, and vitamin D. The cholesterol in the blood comes from 2 sources: the food you eat and production in your liver. 1996-2022 MedicineNet, Inc. All rights reserved. One type of tool is used to cut and remove tissue samples. Call 1800 022 222. email, Recipient's email is invalid. Let us know if you have suggestions to improve this article (requires login). Pap smears are samples of cells taken from the cervix in women to look for cellular changes indicative of cervical cancer. Cholesterol screening is performed by a blood test. This site complies with the HONcode standard for trustworthy health information: verify here. Hemoglobin A1CThis test is used to diagnose and monitor diabetes. It is important to understand that a Pap smear may be referred to as "abnormal," but may not mean that a person has cervical cancer. Complete Blood CountThis test, also known as a CBC, is the most common blood test performed. Admission. Ordinary x-rays are the most common imaging tests. All rights reserved. Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering. It can help evaluate symptoms such as weakness, fatigue and bruising, and can help diagnose conditions such as anemia, leukemia, malaria and infection. Stress-free visits Thus, when doctors get a laboratory test result, the laboratory also gives them its own normal range for that test. A large number of tests are widely available. Where available, ICD-10 codes are listed.[1]. Some organizations, such as the United States Preventive Services Task Force (USPSTF), now recommend against PSA screening. Read more on Pathology Tests Explained website. The link you have selected will take you to a third-party website. My Doctor Says I Have Dense Breasts: What Are Dense Breasts? Copyright 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. present. The 2 most commonly known lipoproteins are low-density lipoproteins (LDL), or "bad" cholesterol, and high-density lipoproteins (HDL), or "good" cholesterol. Thyroid Stimulating HormoneThis test screens and monitors the function of the thyroid. 17-HYDROXYPROGESTERONE NEWBORN SCREEN; CAH SCREEN, 17-HYDROXYCORTICOSTEROIDS (17-OHCS) & 17-KETOSTEROIDS, 24 HOUR URINE, 17-HYDROXYPROGESTERONE (17OHP) STIMULATION BY ACTH, 17-HYDROXYCORTICOSTEROIDS (17-OHCS), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), 24 HOUR URINE, 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), RANDOM URINE, 5 - HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE, ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP, ACETYLCHOLINE RECEPTOR (ACHR) BLOCKING ANTIBODY, ACETYLCHOLINE RECEPTOR (ACHR) MODULATING ANTIBODY, ANTI-ds DNA ANTIBODY CRITHIDIA, IFA IN DILUTIONS, ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), CSF, ANTI MULLERIAN HORMONE (AMH) ULTRASENSITIVE; MENOCHECK, ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) PANEL, SERUM, ANCA (ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES) POSITIVE REFLEX TO ANCA- MPO & ANCA-PR3, ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, CSF, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, SERUM, ACUTE MYELOID LEUKEMIA (AML) CYTOGENETICS PANEL, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, CSF, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE, ADDON-SARS COV-2 (COVID-19) TOTAL ANTIBODIES, SERUM, ADENOVIRUS ANTIGEN FOR GASTROENTERITIS, STOOL, ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS, ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS, ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO, ALCOHOL BIOMARKERS: ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS), URINE, ARTHRITIS & AUTOIMMUNITY AWARENESS (EIA ) SCREENING PACKAGE AAA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) PANEL IgA & IgG, ALLERGY: ASTHMA / RHINITIS SCREENING PANEL, ADULT, ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgG, ALLERGY: WHEEZE / RHINITIS SCREENING PANEL PEDIATRIC, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) PANEL, ALLERGY: ECZEMA PANEL FOR NON-VEGETARIANS, AMINO ACID NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA, AMINO ACID QUANTITATIVE, CSF: 45 AMINO ACIDS / FULL PANEL, ALLERGY: ECZEMA SCREENING PANEL, PEDIATRIC, AMINO ACIDS MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA, ALLERGY: FOOD SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUALITATIVE ONE DIMENSIONAL, URINE, AMINO ACIDS QUALITATIVE TWO DIMENSIONAL, URINE, ALLERGY: INHALATION SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUANTITATIVE, BLOOD: 10 AMINO ACIDS, AMINO ACIDS QUANTITATIVE, PLASMA: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE URINE: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE, URINE & PLASMA: 45 AMINO ACIDS / FULL PANEL, ALLERGY: BERMUDA GRASS (Cynodon dactylon / Doob), AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, AML ETO t(8;21) GENE REARRANGEMENT PCR QUALITATIVE, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, ADULT, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, PEDIATRIC, ALLERGY: PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION, ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE, ALLERGY: COMMON PIGWEED (Kantewali Chauli), ALLERGY SPECIFIC IgG: ALTERNARIA ALTERNATA, ANCA (ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES) EXTENDED PROFILE IgG, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA, ASPERGILLUS ANTIBODIES PANEL IgG & IgM, SERUM, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS, ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA, ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA, AUTOIMMUNE BULLOUS DERMATOSES PROFILE IgG, AUTO IMMUNE ENCEPHALITIS PANEL, SERUM & CSF, AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL, ALLERGY: JOHNSON GRASS (Sorghum halepense / Jowar), ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2), ALLERGY SPECIFIC IgG: CLADOSPORIUM HERBARUM, ANTI-NMO (NEUROMYELITIS OPTICA ) ANTIBODY / AQUAPORIN 4, ALLERGY SPECIFIC IgG: PENICILLIUM CHRYSOGENUM, ALLERGY: MUG WORT (Artemisia vulgaris / Barna), ALLERGY SPECIFIC IgG: PIGEON SERUM PROTEINS, FEATHERS & DROPPINGS, BOH (BAD OBSTETRIC HISTORY) ADVANCED PANEL, BOH (BAD OBSTETRIC HISTORY) EXTENDED PANEL, BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE I C-TELOPEPTIDE, BIOFIRE GI (GASTROINTESTINAL) PANEL, STOOL, BIOFIRE ME (MENINGOENCEPHALITIS) PANEL, CSF, BIOTINIDASE ACTIVITY QUANTITATIVE, BLOOD, BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL, BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL, BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE, BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE, BETA-2 GLYCOPROTEIN 1 PANEL IgG, IgM & IgA, BLOOD GLUCOSE R + CHOLESTEROL TOTAL+ HB% + TSH, BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN), BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE 1C-TELOPEPTIDE, BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION, C1 ESTERASE INHIBITOR FUNCTIONAL; C1 INACTIVATOR FUNCTIONAL, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 DRUGS PANEL, CHROMOSOME ANALYSIS HIGH RESOLUTION, NEONATAL, C1 ESTERASE INHIBITOR PROTEIN QUANTITATION; C1 INHIBITOR QUANTITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 11 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 12 DRUGS PANEL, CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE, BLOOD, CULTURED AFB ANTITUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 4 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMIKACIN, CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN, CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE, CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE, CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL, CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE, CULTURED AFB ANTITUBERCULAR DST, ISONIAZID, CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN, CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN, CA 27.29 & CA 15.3; BREAST CANCER MARKERS PANEL, CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN, CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN, CHIMERISM PRE-ENGRAFTMENT DONOR & RECIPIENT, CHIMERISM SPLIT CELL ANALYSIS - MYELOID CELL (CD15), CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE, CHIMERISM SPLIT CELL ANALYSIS - T Cell (CD3), CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN, CHIMERISM SPLIT CELL ANALYSIS - B CELL (CD19), CALCITONIN STIMULATION BY CALCIUM - PENTAGASTRIN, CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN, CULTURED ANAEROBIC BACTERIA IDENTIFICATION, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE, CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE) SCREENING, CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) SCREENING, CANCER TARGETED GENE PANEL: COLON / COLORECTAL, CULTURE, MYCOBACTERIUM ATYPICAL(NON TUBERCULOUS MYCOBACTERIUM-NTM), CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST), CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM, CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO), CULTURE WATER: PRESUMPTIVE COLIFORM COUNT, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA CONFIRMATION, URINE, CYTOMEGALOVIRUS (CMV) DNA, QUANTITATIVE PCR, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA SCREEN, URINE, CARDIO IQ LIPOPROTEIN FRACTIONATION, ION MOBILITY, CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG, COCAINE AND METABOLITE CONFIRMATION, URINE, CARDIOLIPIN ANTIBODIES PANEL IgG, IgA & IgM, CYSTIC FIBROSIS MUTATION DETECTION, COMPREHENSIVE, CYSTIC FIBROSIS MUTATION DETECTION, DELTA 508, COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTx), RANDOM URINE, CHROMOSOME INTERPHASE PROFILING, AMNIOTIC FLUID, CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION, CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, CONVENTIONAL, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, LIQUID BASED, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRENATAL, CATECHOLAMINES FRACTIONATED, 24-HOUR URINE, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION, CHROMOSOME XON MICROARRAY, HIGH RESOLUTION, CYTOMEGALOVIRUS, INTERFERON GAMMA RELEASE ASSAY (IGRA), CATECHOLAMINES FRACTIONATED, RANDOM URINE, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGNOSTIC PANEL, COMPLETE BLOOD COUNT ADVANCED; CBC ADVANCED, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 1, COMPREHENSIVE DRUG METABOLISM PROFILE -118 DRUGS, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 2, CULTURE AEROBIC BRONCHOALVEOLAR LAVAGE (BAL), CIRCULATING TUMOR CELLS (CTC) FOR BREAST CANCER, CIRCULATING TUMOR CELLS (CTC) FOR COLORECTAL CANCER, CULTURE AEROBIC ENDOTRACHEAL (ET) SECRETIONS, CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER, CONGENITAL HYPOTHYROIDISM CONFIRMATORY PANEL, SERUM, CKD (CHRONIC KIDNEY DISEASE) MANAGEMENT PANEL, CULTURE AEROBIC MISCELLANEOUS WITH GRAM STAIN, CORTISOL SERUM: MORNING & EVENING SAMPLES, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE, CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY, CULTURED AFB ANTITUBERCULAR DST, RAPID 16 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMOXYCLAV, CULTURED AFB ANTITUBERCULAR DST, LINEZOLID, CULTURED AFB ANTITUBERCULAR DST, RAPID 20 DRUGS PANEL, CULTURED AFB DRUG RESISTANT (DR MYCOBACTERIUM) ANTI-TUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS, CULTURED AFB ANTITUBERCULAR DST, RAPID 19 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, CLARITHROMYCIN, CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL, CULTURED AFB ANTITUBERCULAR DST, RIFABUTIN, CULTURED AFB ANTI-TUBERCULAR DST, MEROPENEM, CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE), CULTURED AFB ANTI-TUBERCULAR DST RAPID, PROTHINAMIDE, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION, DPYD (DEOXYPYRIDINOLINE) CROSSLINKS, URINE, DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM, DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, DIALYSIS SARS-CoV-2 (COVID-19) SCREENING PROFILE, DESMOGLEIN (DSG) 1 AND 3 ANTIBODY IN DILUTION/END POINT TITRE, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE, DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION, DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE, DENGUE & CHIKUNGUNYA VIRUSES, PCR QUALITATIVE, DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG, DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED, DLC (DIFFERENTIAL LEUCOCYTE COUNT), FLUID, ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID, ENTEROHEMORRHAGIC E.COLI VEROTOXIN 1 & 2 ANTIGEN, ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM, EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA IN DILUTIONS, EPISODIC ATAXIA COMPREHENSIVE PROFILE, HOTSPOT, EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 23 ANTIGENS, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE, EPSTEIN-BARR VIRUS ANTIBODY TO EARLY ANTIGEN (D), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 18 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO NUCLEAR ANTIGEN (EBNA), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE, 15 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG, ENDOMYSIAL ANTIBODY IgA, IFA IN DILUTIONS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM, EPSTEIN-BARR VIRUS EARLY RNA (EBER-ISH) IN-SITU-HYBRIDIZATION, EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR, EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR, FISH: PRENATAL COMPREHENSIVE SCREENING PANEL 1, FISH: EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT, FISH: FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18), FACTOR XIII (CLOT SOLUBILITY) FUNCTIONAL, QUALITATIVE, FISH: MDS PANEL CHROMOSOMES 5q, 7q, 8q & 20q, FISH: MICRODELETION DETECTION FOR WILLIAMS SYNDROME, FACTOR VIII / FACTOR IX MUTATION ANALYSIS, FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD, FISH: MULTIPLE MYELOMA WITH POSITIVE SELECTION OF CD138 CELLS, FISH: MULTIPLE MYELOMA EXTENDED PANEL WITH POSITIVE SELECTION OF CD138 CELLS: HYPODIPLOIDY/HYPERDIPLOIDY, FISH - Multiple Myeloma with CD138 positive selection cells ( 5 Probes), FISH: t(8;14) OR MYC/IGH FOR BURKITT & NON-HODGKIN LYMPHOMA, FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH), FUNGUS EXAMINATION, ROUTINE: KOH CALCOFLUOR WHITE PREPARATION, FISH: NSCLC (NON-SMALL CELL LUNG CANCER) ALK1 & ROS1, FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION, FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID, FISH: PDGFR ALPHA (4q12) GENE REARRANGEMENT, FISH: 22q DELETION OR LSI Di GEORGE / VCFS, FISH: PDGFR BETA (5q33) GENE REARRANGEMENT, FISH: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) EXTENDED PANEL, HYPODIPLOIDY / HYPERDIPLOIDY, FISH: ACUTE MYELOID LEUKEMIA (AML) / MYELODYSPLASTIC SYNDROME (MDS) THERAPY RELATED, FISH: PRENATAL SCREENING PANEL (CHROMOSOMES 13,18, 21, X & Y), FISH: AMNIO ONE PROBE TRISOMY 21 / DOWN SYNDROME, FISH: AMNIO THREE PROBES TRISOMY 18, X & Y, FRAGILE X TREMOR / ATAXIA SYNDROME (FXTAS), FISH: ANEUPLOIDY DETECTION, PRODUCTS OF CONCEPTION (POC) USING CHROMOSOMES 13, 18, 21, X & Y, FISH: SYNOVIAL SARCOMA (SS18/SYT ) 18q11.2 GENE REARRANGEMENT, FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION, FISH: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) PANEL, FISH: TRISOMY 21 / DOWN SYNDROME, POSTNATAL, GLUCOSE POST PRANDIAL (PP) 2 HOURS POST MEAL, GM2 GANGLIOSIDOSIS QUANTITATIVE, BLOOD; TAY SACHS & SANDHOFF DISEASE, GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE PCR, GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG, GRAM STAIN FOR BACTERIAL VAGINOSIS (BV), VAGINAL SWAB, GALACTOMANNAN (ASPERGILLUS ANTIGEN), BRONCHOALVEOLAR LAVAGE, GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM, GALACTOSEMIA CLASSICAL (TRANSFERASE) QUANTITATIVE, BLOOD, GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG, GALACTOSEMIA (GALT) GENE MUTATION DETECTION, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IgG, GFR (GLOMERULAR FILTRATION RATE), ESTIMATED, GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL, GLUCOSE CHALLENGE TEST (GCT) PREGNANCY, 75g GLUCOSE, GLUCOSE FASTING (F) AND POST MEAL (PP), 2 HOURS, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY,100g GLUCOSE, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IFA, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY, 75g GLUCOSE, HISTOPATHOLOGY SPECIAL STAIN: PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH), HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE, HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE REAL TIME PCR, HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE, HISTOPATHOLOGY SPECIAL STAIN: VAN GIESONS, HCG BETA TOTAL QUANTITATIVE, 24 HOUR URINE, HCG BETA TOTAL QUANTITATIVE, RANDOM URINE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE REAL TIME PCR, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS, HOMA-IR; INSULIN RESISTANCE INDEX C-PEPTIDE MODEL, HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL QUALITATIVE, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IgG ANTIBODIES; DSA-SAB CLASS I & II, HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG, HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING QUALITATIVE PCR, HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST, HLA MIXED ANTIBODY SCREEN: PRA CLASS I, II & MICA, HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL IgG & IgM, SERUM, HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL IgG & IgM, SERUM, HEMOCHROMATOSIS DETECTION HFE GENOTYPING, HUMAN HERPESVIRUS 6 (HHV6) QUALITATIVE PCR, HUMAN HERPES VIRUS 7 (HHV7) QUALITATIVE PCR, HEMOPHILIA A, HEMOPHILIA B & VON WILLEBRAND DISEASE MUTATION DETECTION, HLA-CELIAC DISEASE: DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8, HLA DNA HIGH RESOLUTION TYPING- A, B, C, DR & DQ, HEPARIN INDUCED THROMBOCYTOPENIA (HIT); ANTI PLATELET FACTOR 4-HEPARIN (PF4-H), IgG QUANTITATIVE, HYPOTHYROIDISM / HASHIMOTO'S DISEASE PANEL, HLA DNA HIGH RESOLUTION TYPING: DQB1 LOCUS, H1N1 (SWINE FLU) QUALITATIVE REAL TIME PCR, HLA DNA HIGH RESOLUTION TYPING: DRB1 LOCUS, HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 10 ANTIGENS PCR, HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 6 ANTIGENS LUMINEX, HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT PCR, HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS), HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM, HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL, HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING TEST, HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE, HHH SYNDROME; HYPERORNITHINEMIA - HYPERAMMONEMIA - HOMOCITRULLINURIA SYNDROME, HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC) PHOTOMICROGRAPH, HISTO/CYTOPATHOLOGY SLIDE(S) / BLOCK(S) ISSUE, HISTO/CYTOPATHOLOGY, SLIDES (S) / BLOCKS (S) ISSUE, Hepatitis B Surface Antigen (Hbsag) Rapid Screening, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 6 TO 10 SLIDES, HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 11 TO 20 SLIDES, HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING, HISTO/ IHC DIGITIZATION OF SLIDES, UPTO 5 SLIDES, HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE ULTRA, HLA DSA (DONOR SPECIFIC IgG ANTIBODIES) CLASS I & II, HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR, HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN, HEPATITIS B VIRUS PCR QUALITATIVE; HBV DNA PCR QUALITATIVE, HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN, HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN, HLA HYPERSENSITIVITY TO ABACAVIR (B*57:01), HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58:01), HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15:02), HEPATITIS C VIRAL RNA PCR QUALITATIVE; HCV RNA PCR QUALITATIVE, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY PANEL, HLA-NARCOLEPSY: DRB1*15, DQB1*06:02, DQA1*01:02, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) KIDNEY BIOPSY, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE ULTRA, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS I QUANTITATIVE, Hepatitis C Virus (HCV) Rapid Screening Test, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgA, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) SCREEN, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgG, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPEINT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgM, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3, HEPATITIS G VIRUS (HGV) RNA DETECTION PCR, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4, HISTOPATHOLOGY KIDNEY: BIOPSY SECOND OPINION, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES; DSA-SAB CLASS I, HISTOPATHOLOGY SPECIAL STAIN: ACID FAST (Z N STAIN), HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES; DSA-SAB CLASS II, HISTOPATHOLOGY SPECIAL STAIN: ALCIAN BLUE, HCG BETA TOTAL QUANTITATIVE, TUMOR MARKER, HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL IgG & IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: COPPER (RHODANINE), HERPES SIMPLEX VIRUS (HSV) 1+2 IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: FONTANA MASSON, HISTOPATHOLOGY SPECIAL STAIN: GOMORIS METHENAMINE SILVER, HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: IRON (PERLS STAIN), HERPES SIMPLEX VIRUS (HSV) TYPE 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MASSON TRICHROME, HBDH; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE, HERPES SIMPLEX VIRUS (HSV) TYPE I PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MUCICARMINE, HERPES SIMPLEX VIRUS (HSV) 1+2 IgG, SERUM, HISTOPATHOLOGY SPECIAL STAIN: PERIODIC ACID SCHIFF (PAS), HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN, HERPES VIRUS 6 (HHV-6) ANTIBODIES PANEL IgG & IgM, HISTOPATHOLOGY SPECIAL STAIN: AMYLOID (CONGO RED), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: DOUBLE NEGATIVE T CELLS (DNT), IMMUNOHISTOCHEMISTRY: COMPREHENSIVE PANEL, INS MYCOBACTERIUM TUBERCULOSIS FIRST & SECOND LINE DRUG RESISTANCE PROFILE, IMMUNOHISTOCHEMISTRY: CARBONIC ANHYDRASE-9 (CA-9), Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, IMMUNOHISTOCHEMISTRY: LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD16+56, IMMUNOHISTOCHEMISTRY: MYELOPEROXIDASE (MPO), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34 (STEM CELL) ENUMERATION, IMMUNOHISTOCHEMISTRY: NEUROFILAMENT POLYPEPTIDE, IMMUNOHISTOCHEMISTRY: NEURON SPECIFIC ENOLASE (NSE), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD103, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD10 (CALLA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD117, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD11c, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 1, IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD123, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 3, IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD13, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 4, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD138, IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD14, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD15, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD19, IMMUNOHISTOCHEMISTRY: GLUTAMINE SYNTHETASE, IMMUNOHISTOCHEMISTRY: SERUM ASSOCIATED AMYLOID (SAA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD1a, IMMUNOHISTOCHEMISTRY: GLYCOPHORIN A (GPA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD20, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD22, IMMUNOHISTOCHEMISTRY: TTF-1 (THYROID TRANSCRIPTION FACTOR-1), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD23, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD25, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD33, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34, IMMUNOHISTOCHEMISTRY: LUTEINIZING HORMONE (LH), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD36, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD38, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD41a, IMMUNOHISTOCHEMISTRY: 34-BETA E12 / HMW-CK, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD45, IMMUNOHISTOCHEMISTRY: LMW-CK (LOW MOLECULAR WEIGHT CYTOKERATIN), IMMUNOHISTOCHEMISTRY: ACTIN (SMOOTH MUSCLE ACTIN), IMMUNOHISTOCHEMISTRY: LUNG NON-SMALL CELL CARCINOMA (NSCC) PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD61, IMMUNOHISTOCHEMISTRY: AFP (ALPHA FETO PROTEIN), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD64, IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79a, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79b, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD MPO, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: FMC-7, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: GLYCOPHORIN, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: HLA DR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN CYTOPLASMIC, IMMUNOHISTOCHEMISTRY: NEUROENDOCRINE TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: KAPPA & LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: ZAP-70, IMMUNOHISTOCHEMISTRY: ESTROGEN RECEPTOR (ER), IMMUNOHISTOCHEMISTRY: BREAST CANCER PANEL 2, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD49d, IBD (INFLAMMATORY BOWEL DISEASE) SCREENING PANEL, IMMUNOHISTOCHEMISTRY: ISOCITRATE DEHYDROGENASE (IDH-1), IMMUNOHISTOCHEMISTRY PD-L1 SP263 (VENTANA), IMMUNOHISTOCHEMISTRY PDL1 SP142 (VENTANA), IgVH HYPERMUTATION ANALYSIS, CONFIRMATORY, INFLUENZA LIKE ILLNESS / ILI SARS-CoV-2 (COVID-19) PANEL, IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA, IMMUNOHISTOCHEMISTRY: CEA (CARCINOEMBRYONIC ANTIGEN), IMMUNOHISTOCHEMISTRY: HER-2 / ERBB2 BREAST, IMMUNOHISTOCHEMISTRY: CHROMOGRANIN-A (CGA), IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED, IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC, IMMUNOHISTOCHEMISTRY: CYTOMEGALOVIRUS (CMV), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 19 (CK-19), IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20), IMMUNOHISTOCHEMISTRY: THROMBOSPONDIN (THSD7A), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7), IMMUNOHISTOCHEMISTRY: THYROID CARCINOMA PANEL, IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN), IMMUNOHISTOCHEMISTRY: THYROID STIMULATING HORMONE (TSH), IMMUNOHISTOCHEMISTRY: SINGLE MARKER WITHOUT IINTERPRETATION, IMMUNOFIXATION ELECTROPHORESIS (IFE), 24 HOUR URINE, IMMUNOHISTOCHEMISTRY: EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), IMMUNOHISTOCHEMISTRY: ANY 5 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: EPITHELIAL MEMBRANE ANTIGEN (EMA), IMMUNOHISTOCHEMISTRY: ANY 3 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: FOLLICLE STIMULATING HORMONE (FSH), IMMUNOHISTOCHEMISTRY: GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP), IMMUNOHISTOCHEMISTRY: GROWTH HORMONE (GH), IMMUNOHISTOCHEMISTRY: HEPATOCYTE SPECIFIC ANTIGEN (HSA), INSULIN FASTING (F) & POST PRANDIAL (PP) PANEL, IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE, INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; IL-2R, INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING QUALITATIVE PCR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: OBSTETRIC PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LYMPHOMA DIAGNOSTIC PANEL, IMMUNOHISTOCHEMISTRY: BLADDER VS PROSTATE CARCINOMA PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY: GERM CELL TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS, IMMUNOHISTOCHEMISTRY, PITUITARY ADENOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA -T, B or MYELOID, IMMUNOHISTOCHEMISTRY, PROSTATE BENIGN VS MALIGNANT PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL-CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL- CLL/HCL/SLL BASIC, IMMUNOHISTOCHEMISTRY: ANDROGEN RECEPTOR (AR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA MONITORING PANEL-HAIRY CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-PLASMA CELL DYSCRASIAS, IMMUNOHISTOCHEMISTRY: HUMAN CHORIONIC GONADOTROPIN (HCG), IMMUNOHISTOCHEMISTRY: TRIPLE NEGATIVE BREAST CANCER (TNBC) PANEL, JAK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION, JAK 2 V617F, CALR & MPL MUTATION DETECTION PROFILE, JAPANESE ENCEPHALITIS VIRUS (JEV) DETECTION PCR, KETONE BODY (BETA HYDROXYBUTYRATE), SERUM, KIDNEY BIOSPY / ELECTRON MICROSCOPY, SLIDES / IMAGES ISSUE, KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL, LUNG CANCER 12 GENE PANEL WITH PDL1 - VENTANA SP263, LEUKEMIA GENETIC PROFILE: ANY 6 MARKERS PCR QUALITATIVE, LEISHMANIA (KALA AZAR) rK-39 ANTIBODY, SERUM, LUNG CANCER PANEL: 12 GENE WITH PDL1 - VENTANA SP142, LIPOPROTEIN FRACTIONATION, ULTRACENTRIFUGATION, LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES IgG & IgM, LYME DISEASE (BORRELIA BURGDORFERI) DNA QUALITATIVE REAL TIME PCR, LYME DISEASE (BORRELIA BURGDORFERI) IgG & IgM IMMUNOBLOT, LYME DISEASE (BORRELIA BURGDORFERI) IgG IMMUNOBLOT, LYMPHOCYTE SUBSET ENUMERATION (TBNK) FOR COVID SEVERITY ASSESSMENT, LIVER KIDNEY MICROSOMAL 1 (LKM 1) ANTIBODY EIA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IFA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA, LEGIONELLA PNEUMOPHILA IgG ANTIBODY, SERUM, LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION, LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION, LEPTOSPIRA ANTIBODIES PANEL IgG & IgM, EIA, LEUCOCYTE ADHESION DEFICIENCY (LAD I & II), Lp-PLA2 (LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2) ACTIVITY, LERGY SPECIFIC IgG: ASPERGILLUS FUMIGATUS, MYCOPLASMA PNEUMONIAE IgG & IgM ANTIBODIES PANEL, SERUM, MITOCHONDRIAL ANTIBODY (AMA) IFA IN DILUTIONS, MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES) MUTATION DETECTION, MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE, MYELIN ASSOCIATED GLYCOPROTEIN (MAG) IgM, METACHROMATIC LEUCODYSTROPHY QUANTITATIVE, BLOOD, MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA, MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS, MYELIN ASSOCIATED GLYCOPROTEIN- SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY (MAG-SGPG) IgM, METANEPHRINES FRACTIONATED, 24 HOUR URINE, METANEPHRINES FRACTIONATED, RANDOM URINE, MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR B-CLL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR MULTIPLE MYELOMA, MICM (MATERNALLY INHERITED CARDIOMYOPATHY) MUTATION DETECTION, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION, MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE, MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT, MITOCHONDRIAL SEQUENCING: WHOLE MITOCHONDRIAL GENOME SEQUENCING, MICROALBUMIN / ALBUMIN CREATININE RATIO, URINE, MATERNAL SERUM SCREEN 2: ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA (MBFD)/NIPT CHROMOSOME 21, MIXING STUDIES: APTT WITH PROTHROMBIN TIME STUDIES, MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC, MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY) MUTATION DETECTION, MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) PANEL, MUMPS VIRUS ANTIBODIES PANEL IgG & IgM, SERUM, MEASLES (RUBEOLA) ANTIBODIES PANEL IgG & IgM, SERUM, MPL (MYELOPROLIFERATIVE LEUKEMIA) GENE MUTATION, MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR, MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE, MUCOPOLYSACCHARIDOSIS (MPS) TYPE 1 (HURLER) QUANTITATIVE, BLOOD, MEDULLARY THYROID CARCINOMA MUTATION DETECTION, MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY) QUANTITATIVE, BLOOD, MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; VAN DER KNAAP AND NALBAND MLC GENE HOTSPOT MUTATION, MUCOPOLYSACCHARIDOSIS (MPS) TYPING, 24 HOUR URINE, MEMBRANOUS GLOMERULOPATHY (MGN): TARGET 5 ANTIGENS PANEL, MEMBRANOUS GLOMERULOPATHY (MGN) PLA2R NEGATIVE : TARGET 4 ANTIGENS PANEL, MYCOBACTERIUM TUBERCULOSIS PCR; MYCOSURE; TB PCR, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS, MYCOBACTERIUM TUBERCULOSIS rRNA DETECTION, TMA, NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE, Nx GEN SEQUENCING: HEREDITARY RETINOBLASTOMA, Nx GEN SEQUENCING: LEBER CONGENITAL AMAUROSIS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ULTRA, Nx GEN SEQUENCING: MEGALOENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, Nx GEN SEQUENCING: MICROPHTHALMIA / ANOPHTHALMIA / COLOBOMA SPECTRUM, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ADVANCED, NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR, NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR, NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE), NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE, Nx GEN SEQUENCING: BETHLEM MYOPATHY, MYOFIBRILLAR MYOPATHY & ULLRICH MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: CHARCOT-MARIE-TOOTH DISEASE & SENSORY NEUROPATHIES, Nx GEN CLINICAL EXOME SEQUENCING, ILLUMINA, Nx GEN SEQUENCING: DRAVET'S SYNDROME & EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY, Nx GEN SEQUENCING: DUCHENNE & BECKER MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: MATURITY ONSET DIABETES OF YOUNG (MODY), Nx GEN SEQUENCING: TUBEROUS SCLEROSIS COMPLEX, Nx GEN SEQUENCING: AICARDI-GOUTIERES SYNDROME, Nx GEN SEQUENCING: AMYOTROPHIC LATERAL SCLEROSIS, NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN), URINE, Nx GEN SEQUENCING: FAMILIAL HEMIPLEGIC MIGRAINE, Nx GEN SEQUENCING: COMPREHENSIVE EPILEPSY, OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST, ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL, ONCOMINE CHRONIC MYELOID LEUKAEMIA (CML) PANEL, ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL, ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) PANEL, ONCOMINE MYELODYSPLASTIC SYNDROME(MDS) PANEL, ONCOMINE MYELOPROLIFERATIVE NEOPLASM (MPN) PANEL, ONCOPRO COMPREHENSIVE CANCER PANEL: 161 GENES, OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL, ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS, P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE) TOTAL, PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1), PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING, PRIMARY IMMUNE DEFICIENCY SCREENING PANEL (PIDOT), PAN FUNGAL DETECTION AND IDENTIFICTION, PCR, PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A), PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE PCR, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE PCR, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) CONFIRMATORY TEST, PARTIAL THROMBOPLASTIN TIME ACTIVATED; PTT; APTT, PROSTATE TRUS BIOPSY AI PANEL REFLEX TO IMMUNOHISTOCHEMISTRY, PARVOVIRUS B19 ANTIBODIES PANEL IgG & IgM, PORPHYRINS TOTAL QUALITATIVE, RANDOM URINE, PORPHYRINS TOTAL QUANTITATIVE, 24- HOUR URINE, PROTEIN ELECTROPHORESIS & IMMUNOTYPING, SERUM, PRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR, PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL, PHOSPHATIDYLSERINE ANTIBODIES PANEL IgG & IgM, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUANTITATIVE, PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR, PTHrP; PARATHYROID HORMONE RELATED PROTEIN, PORPHOBILINOGEN (PBG) QUANTITATIVE, 24 HOUR URINE, PURKINJE CELL (Yo) ANTIBODY SCREEN, WITH REFLEX TO TITER AND WESTERN BLOT, CSF, PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN) ANTIBODY, PURKINJE CELL CYTOPLASMIC ANTIBODY TYPE Tr (DNER), PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, PIIINP (PROCOLLAGEN TYPE III AMINO TERMINAL PROPEPTIDE), Q FEVER (COXIELLA BURNETTI) ANTIBODIES IgG & IgM, QuantiFERON-TB Gold (QFT), INTERFERON GAMMA RELEASE ASSAY (IGRA), QuantiFERON-TB GOLD PLUS (QFT-PLUS), INTERFERON GAMMA RELEASE ASSAY (IGRA), ROCKY MOUNTAIN SPOTTED FEVER ANTIBODIES, ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM, RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL, RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL IgG & IgM, RS-CSARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY QUANTITATIVE, RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, BASIC, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, EXTENDED, SARS-CoV-2 (COVID-19) NEUTRALIZING ANTIBODY, Swasthfit Advance Health Checkup - Full Body Checkup, SARS-COV-2 (COVID-19) RESPIRATORY COMPREHENSIVE PANEL, SCA-11 (SPINOCEREBELLAR ATAXIA): TTBK2 GENE MUTATION, SCA-12 (SPINOCEREBELLAR ATAXIA): PPP2R2B GENE MUTATION, SCA-17 (SPINOCEREBELLAR ATAXIA): TBP GENE MUTATION, SWASTHFIT COMPLETE PACKAGE WITH FREE WELLNESS REPORT, SCA-1 (SPINOCEREBELLAR ATAXIA): ATXN1 GENE MUTATION, SOLUBLE TRANSFERRIN RECEPTOR (sTfR), SERUM, Swasthfit Heart Check - Advance Health Checkup, SCA-2 (SPINOCEREBELLAR ATAXIA): ATXN2 GENE MUTATION, SCA-3 (SPINOCEREBELLAR ATAXIA): ATXN3 GENE MUTATION, SCA-5 (SPINOCEREBELLAR ATAXIA): SPTBN2 GENE MUTATION, SCA-6 (SPINOCEREBELLAR ATAXIA): CACNA1A GENE MUTATION, SPERM DNA FRAGMENTATION FLUORESCENT MICROSCOPY, SCA-7 (SPINOCEREBELLAR ATAXIA): ATXN7 GENE MUTATION, SCA-8 (SPINOCEREBELLAR ATAXIA): ATXN8OS & ATXN8 GENE MUTATION, Swasthfit Pro 3 (With Free Doctor Consultation), SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE, SPINAL MUSCULAR ATROPHY (SMA) CARRIER DETECTION, SPINAL MUSCULAR ATROPHY (SMA) MUTATION DETECTION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODIES PANEL IgG & IgM, SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS, SCA-23 (SPINOCEREBELLAR ATAXIA): PDYN GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, EIA, SCA-14 (SPINOCEREBELLAR ATAXIA): PRKCG GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, EIA, Swasthfit Total - Heart Check - Full Body Checkup, Swasthfit Total - Iron Check - Full Body Checkup, STEROID PANEL: 21- HYDROXYLASE DEFICIENCY, STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH), STEROID PANEL FOR PCOS / NON-CLASSICAL CAH DIFFERENTIATION, STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS), SICKLE CELL ANEMIA TRIO PRENATAL MUTATION DETECTION, STOOL EXAMINATION HANGING DROP PREPARATION, STOOL EXAMINATION pH & REDUCING SUBSTANCES, STREPTOCOCCUS GROUP B ANTIGEN DETECTION, SARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY PLUS, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA, SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA IN DILUTIONS, Swasthfit Tax Saver Basic Health Checkup - Full Body Checkup, SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR, Swasthfit Tax Saver Advance Health Checkup - Full Body Checkup, SMOOTH MUSCLE ANTIBODY (ASMA) IFA IN DILUTIONS, SCA (SPINOCEREBELLAR ATAXIA: EXTENDED PROFILE, TOTAL WBC COUNT & DIFFERENTAL COUNT & ESR, THALASSEMIA BETA TRIO PRENATAL MUTATION DETECTION, TB LAMP (LOOP MEDIATED ISOTHERMA AMPLIFICATION) QUALITATIVE DNA PCR, MYCOBACTERIUM TUBERCULOSIS COMPLEX, TB PLATINUM INTERFERON GAMMA RELEASE ASSAY (IGRA), TOXOPLASMA ANTIBODIES PANEL IgG & IgM, SERUM, TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION, TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING, TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, CORD BLOOD, TSI; THYROID STIMULATING IMMUNOGLOBULIN, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgA, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgG, TYPHUS FEVER (RICKETTSIA) ANTIBODIES IgG & IgM, TESTOSTERONE FREE & SEX HORMONE BINDING GLOBULIN, THALASSEMIA ALPHA TRIO PRENATAL MUTATION DETECTION, t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE, t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE, t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE, t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE, t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE, URINE EXAMINATION ROUTINE; URINE R/E AUTOMATED, UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE 'TA' REPEATS) DETECTION, VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD, VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) SCREENING, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, CSF, VITAMIN B12 BINDING CAPACITY UNSATURATED; TRANSCOBALAMIN, VARICELLA ZOSTER VIRUS (VZV) QUALITATIVE PCR, VMA (VANILLYL MANDELIC ACID), 24 HOUR URINE, VMA (VANILLYL MANDELIC ACID), RANDOM URINE, VON WILLEBRAND FACTOR COLLAGEN BINDING ACTIVITY (vWF:CB), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM, VON WILLEBRAND FACTOR RISTOCETIN COFACTOR ACTIVITY (vWF:RCo), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, CSF, VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL IgG & IgM, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgM, SERUM, von WILLEBRAND FACTOR ANTIGEN; vWF Ag, Y-CHROMOSOME MICRODELETION DETECTION , PCR, YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING.
Disease articles are written by U.S. Board Certified Physicians. This page aggregates information that directly links to Pathology Tests Explained. However, the liver produces all of the cholesterol the body needs. Could a Common Diabetes Drug Ease Bipolar Disorder. This information is for people who want to find out more about why they have been asked to have a diagnostic test and what it could involve so that they can make an informed choice about it. 200 SE Hospital Ave. That is, 95% of healthy people have values within this range. While every effort has been made to follow citation style rules, there may be some discrepancies. These tests are usually performed in a consulting room by any doctor and require no advanced equipment. recent indian singh march india does programme under national swachh launched A blood test may show that a person has too few red blood cells (anemia). 'On Edge': Anxious Americans Line Up for Scarce Monkeypox Vaccines, Alternative Medicine Popular Among Seniors, But Most Don't Tell Their Doctors About It, Biden Tests Negative for COVID, Ends Isolation Period. Comprehensive Metabolic PanelThis test combines the Basic Metabolic Panel with six more tests for a more comprehensive evaluation of metabolic functions, with a focus on organ systems. Alpha Fetoprotein (AFP) Tumor Marker Test, Antineutrophil Cytoplasmic Antibodies (ANCA) Test, Beta 2 Microglobulin (B2M) Tumor Marker Test, Bronchoscopy and Bronchoalveolar Lavage (BAL), Developmental and Behavioral Screening Tests, Electromyography (EMG) and Nerve Conduction Studies, Estrogen Receptor, Progesterone Receptor Tests, Fetal Alcohol Spectrum Disorders (FASD) Screening, Follicle-Stimulating Hormone (FSH) Levels Test, IGF-1 (Insulin-like Growth Factor 1) Test, Lactate Dehydrogenase (LDH) Isoenzymes Test, Natriuretic Peptide Tests (BNP, NT-proBNP), Total Protein and Albumin/Globulin (A/G) Ratio, What You Need to Know About Blood Testing, U.S. Department of Health and Human Services. We pay our respects to the Traditional Owners and to Elders both past and Abdominoplasty (Tummy Tuck ( Abdominoplasty)), Ablation, Endometrial (Endometrial Ablation), Abnormal Liver Enzymes (Liver Blood Tests), Absorbent Products Incontinence (Urinary Incontinence Products for Men), Abstinence Method of Birth Control (Natural Methods of Birth Control), Adenosine Stress Test For Heart Disease (Coronary Artery Disease Screening Tests (CAD)), AFP Blood Test (Alpha-fetoprotein Blood Test), Alexander Technique for Childbirth (Childbirth Class Options), Allergy, Skin Test (Skin Test For Allergy), Annulus Support (Heart Valve Disease Treatment), Anti-citrulline Antibody (Citrulline Antibody), Anti-cyclic Citrullinated Peptide Antibody (Citrulline Antibody), Antibiotic Prophylactic Regimens for Endocarditis, Antimicrosomal Antibody Test (Thyroid Peroxidase Test), Antithyroid Microsomal Antibody Test (Thyroid Peroxidase Test), Aortic Heart Valve Replacement (Heart Valve Disease Treatment), Appendectomy recovery complications prognosis, Arrhythmia Treatment (Ablation Therapy for Arrhythmias), Arthritis Physical and Occupational Therapy, Arthroplasty (Joint Replacement Surgery Of The Hand), Auditory Brainstem Response (Newborn Infant Hearing Screening). We've got you covered. bsi thucydides asks tantalus enormous 
If you need urgent medical help, call triple zero immediately. Regular eye tests can pick up problems before you notice any symptoms and you dont need a referral to see an optometrist. This test is done in conjunction with a clinical breast exam, Many organizations, including the USPSTF, recommend screening for colon cancer or colon polyps at age 50, earlier if you have a family history or other risk factors. We currently support Microsoft Edge, Chrome, Firefox and Safari. P.O. A viewing tube (endoscope) is used to directly observe the inside of body organs or spaces (cavities). Copyright 2022 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. Free Australian health advice you can count on. Find out about the screening and diagnostic tests that can detect the condition. InsideRadiology provides free and easily accessible, accurate, up to date and credible information about medical imaging tests and procedures. Liver PanelThe liver panel is a combination of tests used to assess liver function and establish the possible presence of liver tumors. The tip of the endoscope is usually equipped with a light and a camera, so the examiner watches the images on a television monitor rather than looking directly through the endoscope. Terms of Service apply. Testing is recommended starting at age 50 by many organizations including the American Cancer Society. Find out whats involved. Tests are usually one of the six following types. While screening tests are not 100% accurate in all cases, it is generally more valuable to have the screening tests at the appropriate times, as recommended by your healthcare provider, than to not have them at all. Tradition Pharmacy Martin Health Physician Group New Patient Information Form (MHPG) Cancer Services Neurosciences Fitness Centers Wellness Support Services Community Benefit Compliance and Privacy , 772.287.5200 At Another Johns Hopkins Member Hospital: Mammograms and More: Breast Cancer Screening Guidelines, Virtual Colonoscopy Screening to Combat Colon Cancer. Studies have shown that people with high cholesterol can reduce their risk for heart disease by lowering their cholesterol. There are different types of medical tests but the lines that separate them often become blurred. Best in Northern CA Learn about medical tests, including what the tests are A biopsy helps a doctor diagnose a medical condition. It includes cholesterol and triglyceride levels. Our specialists handle conditions ranging from the common to the most rare. Screening tests are not considered diagnostic, but are used to identify a subset of the population who should have additional testing to determine the presence or absence of disease. Please enter manually below. Lipid PanelThe lipid panel is a group of tests used to evaluate cardiac risk. Terms of Use. Looks like youre visiting Benioff Children's Hospitals on Internet Explorer. Sometimes a test is used for more than one purpose. For more information, see www.labtestsonline.org, a public resource on clinical laboratory testing. Some of the cons include unnecessary testing and procedures, unnecessary costs, and significantly increased anxiety. Additionally, individuals without symptoms of diabetes should be screened if they are overweight or obese and have one or more additional diabetes risk factors. The pros and cons of PSA screening should always be discussed with your healthcare provider before testing. It is grouped by type of procedure and ordered alphabetically. This pathway provides guidance on the staging of adult patients with renal carcinoma confirmed by biopsy or previous imaging. The test is a simple procedure to check the health of a persons cervix, it is expected to protect up to 30% more people than the pap smear was able to. An MRI scanner uses strong magnetic fields, radio waves and a computer to take pictures of the soft tissue inside of your body. Fecal occult blood is detected by microscopic analysis or by chemical tests for hemoglobin (blood) in the stool. It aids in the production of cell membranes, some hormones, and vitamin D. The cholesterol in the blood comes from 2 sources: the food you eat and production in your liver. 1996-2022 MedicineNet, Inc. All rights reserved. One type of tool is used to cut and remove tissue samples. Call 1800 022 222. email, Recipient's email is invalid. Let us know if you have suggestions to improve this article (requires login). Pap smears are samples of cells taken from the cervix in women to look for cellular changes indicative of cervical cancer. Cholesterol screening is performed by a blood test. This site complies with the HONcode standard for trustworthy health information: verify here. Hemoglobin A1CThis test is used to diagnose and monitor diabetes. It is important to understand that a Pap smear may be referred to as "abnormal," but may not mean that a person has cervical cancer. Complete Blood CountThis test, also known as a CBC, is the most common blood test performed. Admission. Ordinary x-rays are the most common imaging tests. All rights reserved. Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering. It can help evaluate symptoms such as weakness, fatigue and bruising, and can help diagnose conditions such as anemia, leukemia, malaria and infection. Stress-free visits Thus, when doctors get a laboratory test result, the laboratory also gives them its own normal range for that test. A large number of tests are widely available. Where available, ICD-10 codes are listed.[1]. Some organizations, such as the United States Preventive Services Task Force (USPSTF), now recommend against PSA screening. Read more on Pathology Tests Explained website. The link you have selected will take you to a third-party website. My Doctor Says I Have Dense Breasts: What Are Dense Breasts? Copyright 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. present. The 2 most commonly known lipoproteins are low-density lipoproteins (LDL), or "bad" cholesterol, and high-density lipoproteins (HDL), or "good" cholesterol. Thyroid Stimulating HormoneThis test screens and monitors the function of the thyroid. 17-HYDROXYPROGESTERONE NEWBORN SCREEN; CAH SCREEN, 17-HYDROXYCORTICOSTEROIDS (17-OHCS) & 17-KETOSTEROIDS, 24 HOUR URINE, 17-HYDROXYPROGESTERONE (17OHP) STIMULATION BY ACTH, 17-HYDROXYCORTICOSTEROIDS (17-OHCS), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), 24 HOUR URINE, 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5-ALA), RANDOM URINE, 5 - HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE, ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP, ACETYLCHOLINE RECEPTOR (ACHR) BLOCKING ANTIBODY, ACETYLCHOLINE RECEPTOR (ACHR) MODULATING ANTIBODY, ANTI-ds DNA ANTIBODY CRITHIDIA, IFA IN DILUTIONS, ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), CSF, ANTI MULLERIAN HORMONE (AMH) ULTRASENSITIVE; MENOCHECK, ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) PANEL, SERUM, ANCA (ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES) POSITIVE REFLEX TO ANCA- MPO & ANCA-PR3, ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, CSF, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, SERUM, ACUTE MYELOID LEUKEMIA (AML) CYTOGENETICS PANEL, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, CSF, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE, ADDON-SARS COV-2 (COVID-19) TOTAL ANTIBODIES, SERUM, ADENOVIRUS ANTIGEN FOR GASTROENTERITIS, STOOL, ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS, ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS, ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO, ALCOHOL BIOMARKERS: ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS), URINE, ARTHRITIS & AUTOIMMUNITY AWARENESS (EIA ) SCREENING PACKAGE AAA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) PANEL IgA & IgG, ALLERGY: ASTHMA / RHINITIS SCREENING PANEL, ADULT, ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgG, ALLERGY: WHEEZE / RHINITIS SCREENING PANEL PEDIATRIC, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) PANEL, ALLERGY: ECZEMA PANEL FOR NON-VEGETARIANS, AMINO ACID NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA, AMINO ACID QUANTITATIVE, CSF: 45 AMINO ACIDS / FULL PANEL, ALLERGY: ECZEMA SCREENING PANEL, PEDIATRIC, AMINO ACIDS MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA, ALLERGY: FOOD SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUALITATIVE ONE DIMENSIONAL, URINE, AMINO ACIDS QUALITATIVE TWO DIMENSIONAL, URINE, ALLERGY: INHALATION SCREENING PANEL FOR INDIAN POPULATION, AMINO ACIDS QUANTITATIVE, BLOOD: 10 AMINO ACIDS, AMINO ACIDS QUANTITATIVE, PLASMA: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE URINE: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE, URINE & PLASMA: 45 AMINO ACIDS / FULL PANEL, ALLERGY: BERMUDA GRASS (Cynodon dactylon / Doob), AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, AML ETO t(8;21) GENE REARRANGEMENT PCR QUALITATIVE, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, ADULT, ALLERGY: WHEEZE / RHINITIS COMPREHENSIVE PANEL, PEDIATRIC, ALLERGY: PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION, ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE, ALLERGY: COMMON PIGWEED (Kantewali Chauli), ALLERGY SPECIFIC IgG: ALTERNARIA ALTERNATA, ANCA (ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES) EXTENDED PROFILE IgG, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA, ASPERGILLUS ANTIBODIES PANEL IgG & IgM, SERUM, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS, ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA, ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA, AUTOIMMUNE BULLOUS DERMATOSES PROFILE IgG, AUTO IMMUNE ENCEPHALITIS PANEL, SERUM & CSF, AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL, ALLERGY: JOHNSON GRASS (Sorghum halepense / Jowar), ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2), ALLERGY SPECIFIC IgG: CLADOSPORIUM HERBARUM, ANTI-NMO (NEUROMYELITIS OPTICA ) ANTIBODY / AQUAPORIN 4, ALLERGY SPECIFIC IgG: PENICILLIUM CHRYSOGENUM, ALLERGY: MUG WORT (Artemisia vulgaris / Barna), ALLERGY SPECIFIC IgG: PIGEON SERUM PROTEINS, FEATHERS & DROPPINGS, BOH (BAD OBSTETRIC HISTORY) ADVANCED PANEL, BOH (BAD OBSTETRIC HISTORY) EXTENDED PANEL, BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE I C-TELOPEPTIDE, BIOFIRE GI (GASTROINTESTINAL) PANEL, STOOL, BIOFIRE ME (MENINGOENCEPHALITIS) PANEL, CSF, BIOTINIDASE ACTIVITY QUANTITATIVE, BLOOD, BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL, BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL, BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE, BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE, BETA-2 GLYCOPROTEIN 1 PANEL IgG, IgM & IgA, BLOOD GLUCOSE R + CHOLESTEROL TOTAL+ HB% + TSH, BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN), BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE 1C-TELOPEPTIDE, BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION, C1 ESTERASE INHIBITOR FUNCTIONAL; C1 INACTIVATOR FUNCTIONAL, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 DRUGS PANEL, CHROMOSOME ANALYSIS HIGH RESOLUTION, NEONATAL, C1 ESTERASE INHIBITOR PROTEIN QUANTITATION; C1 INHIBITOR QUANTITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 11 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 12 DRUGS PANEL, CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE, BLOOD, CULTURED AFB ANTITUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 4 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMIKACIN, CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN, CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE, CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE, CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL, CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE, CULTURED AFB ANTITUBERCULAR DST, ISONIAZID, CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN, CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN, CA 27.29 & CA 15.3; BREAST CANCER MARKERS PANEL, CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN, CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN, CHIMERISM PRE-ENGRAFTMENT DONOR & RECIPIENT, CHIMERISM SPLIT CELL ANALYSIS - MYELOID CELL (CD15), CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE, CHIMERISM SPLIT CELL ANALYSIS - T Cell (CD3), CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN, CHIMERISM SPLIT CELL ANALYSIS - B CELL (CD19), CALCITONIN STIMULATION BY CALCIUM - PENTAGASTRIN, CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN, CULTURED ANAEROBIC BACTERIA IDENTIFICATION, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE, CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE) SCREENING, CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) SCREENING, CANCER TARGETED GENE PANEL: COLON / COLORECTAL, CULTURE, MYCOBACTERIUM ATYPICAL(NON TUBERCULOUS MYCOBACTERIUM-NTM), CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST), CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM, CANCER TARGETED GENE PANEL : LUNG WITH PDL-1 (DAKO), CULTURE WATER: PRESUMPTIVE COLIFORM COUNT, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA CONFIRMATION, URINE, CYTOMEGALOVIRUS (CMV) DNA, QUANTITATIVE PCR, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA SCREEN, URINE, CARDIO IQ LIPOPROTEIN FRACTIONATION, ION MOBILITY, CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG, COCAINE AND METABOLITE CONFIRMATION, URINE, CARDIOLIPIN ANTIBODIES PANEL IgG, IgA & IgM, CYSTIC FIBROSIS MUTATION DETECTION, COMPREHENSIVE, CYSTIC FIBROSIS MUTATION DETECTION, DELTA 508, COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTx), RANDOM URINE, CHROMOSOME INTERPHASE PROFILING, AMNIOTIC FLUID, CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION, CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, CONVENTIONAL, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, LIQUID BASED, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRENATAL, CATECHOLAMINES FRACTIONATED, 24-HOUR URINE, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION, CHROMOSOME XON MICROARRAY, HIGH RESOLUTION, CYTOMEGALOVIRUS, INTERFERON GAMMA RELEASE ASSAY (IGRA), CATECHOLAMINES FRACTIONATED, RANDOM URINE, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PROGNOSTIC PANEL, COMPLETE BLOOD COUNT ADVANCED; CBC ADVANCED, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 1, COMPREHENSIVE DRUG METABOLISM PROFILE -118 DRUGS, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION PANEL 2, CULTURE AEROBIC BRONCHOALVEOLAR LAVAGE (BAL), CIRCULATING TUMOR CELLS (CTC) FOR BREAST CANCER, CIRCULATING TUMOR CELLS (CTC) FOR COLORECTAL CANCER, CULTURE AEROBIC ENDOTRACHEAL (ET) SECRETIONS, CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER, CONGENITAL HYPOTHYROIDISM CONFIRMATORY PANEL, SERUM, CKD (CHRONIC KIDNEY DISEASE) MANAGEMENT PANEL, CULTURE AEROBIC MISCELLANEOUS WITH GRAM STAIN, CORTISOL SERUM: MORNING & EVENING SAMPLES, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE, CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY, CULTURED AFB ANTITUBERCULAR DST, RAPID 16 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, AMOXYCLAV, CULTURED AFB ANTITUBERCULAR DST, LINEZOLID, CULTURED AFB ANTITUBERCULAR DST, RAPID 20 DRUGS PANEL, CULTURED AFB DRUG RESISTANT (DR MYCOBACTERIUM) ANTI-TUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS, CULTURED AFB ANTITUBERCULAR DST, RAPID 19 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, CLARITHROMYCIN, CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL, CULTURED AFB ANTITUBERCULAR DST, RIFABUTIN, CULTURED AFB ANTI-TUBERCULAR DST, MEROPENEM, CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE), CULTURED AFB ANTI-TUBERCULAR DST RAPID, PROTHINAMIDE, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION, DPYD (DEOXYPYRIDINOLINE) CROSSLINKS, URINE, DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM, DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, DIALYSIS SARS-CoV-2 (COVID-19) SCREENING PROFILE, DESMOGLEIN (DSG) 1 AND 3 ANTIBODY IN DILUTION/END POINT TITRE, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE, DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION, DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE, DENGUE & CHIKUNGUNYA VIRUSES, PCR QUALITATIVE, DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG, DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED, DLC (DIFFERENTIAL LEUCOCYTE COUNT), FLUID, ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID, ENTEROHEMORRHAGIC E.COLI VEROTOXIN 1 & 2 ANTIGEN, ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM, EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA IN DILUTIONS, EPISODIC ATAXIA COMPREHENSIVE PROFILE, HOTSPOT, EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 23 ANTIGENS, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE, EPSTEIN-BARR VIRUS ANTIBODY TO EARLY ANTIGEN (D), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA) QUALITATIVE PROFILE, 18 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO NUCLEAR ANTIGEN (EBNA), IgG, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE, 15 ANTIGENS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG, ENDOMYSIAL ANTIBODY IgA, IFA IN DILUTIONS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM, EPSTEIN-BARR VIRUS EARLY RNA (EBER-ISH) IN-SITU-HYBRIDIZATION, EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR, EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR, FISH: PRENATAL COMPREHENSIVE SCREENING PANEL 1, FISH: EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT, FISH: FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18), FACTOR XIII (CLOT SOLUBILITY) FUNCTIONAL, QUALITATIVE, FISH: MDS PANEL CHROMOSOMES 5q, 7q, 8q & 20q, FISH: MICRODELETION DETECTION FOR WILLIAMS SYNDROME, FACTOR VIII / FACTOR IX MUTATION ANALYSIS, FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD, FISH: MULTIPLE MYELOMA WITH POSITIVE SELECTION OF CD138 CELLS, FISH: MULTIPLE MYELOMA EXTENDED PANEL WITH POSITIVE SELECTION OF CD138 CELLS: HYPODIPLOIDY/HYPERDIPLOIDY, FISH - Multiple Myeloma with CD138 positive selection cells ( 5 Probes), FISH: t(8;14) OR MYC/IGH FOR BURKITT & NON-HODGKIN LYMPHOMA, FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH), FUNGUS EXAMINATION, ROUTINE: KOH CALCOFLUOR WHITE PREPARATION, FISH: NSCLC (NON-SMALL CELL LUNG CANCER) ALK1 & ROS1, FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION, FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID, FISH: PDGFR ALPHA (4q12) GENE REARRANGEMENT, FISH: 22q DELETION OR LSI Di GEORGE / VCFS, FISH: PDGFR BETA (5q33) GENE REARRANGEMENT, FISH: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) EXTENDED PANEL, HYPODIPLOIDY / HYPERDIPLOIDY, FISH: ACUTE MYELOID LEUKEMIA (AML) / MYELODYSPLASTIC SYNDROME (MDS) THERAPY RELATED, FISH: PRENATAL SCREENING PANEL (CHROMOSOMES 13,18, 21, X & Y), FISH: AMNIO ONE PROBE TRISOMY 21 / DOWN SYNDROME, FISH: AMNIO THREE PROBES TRISOMY 18, X & Y, FRAGILE X TREMOR / ATAXIA SYNDROME (FXTAS), FISH: ANEUPLOIDY DETECTION, PRODUCTS OF CONCEPTION (POC) USING CHROMOSOMES 13, 18, 21, X & Y, FISH: SYNOVIAL SARCOMA (SS18/SYT ) 18q11.2 GENE REARRANGEMENT, FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION, FISH: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) PANEL, FISH: TRISOMY 21 / DOWN SYNDROME, POSTNATAL, GLUCOSE POST PRANDIAL (PP) 2 HOURS POST MEAL, GM2 GANGLIOSIDOSIS QUANTITATIVE, BLOOD; TAY SACHS & SANDHOFF DISEASE, GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE PCR, GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG, GRAM STAIN FOR BACTERIAL VAGINOSIS (BV), VAGINAL SWAB, GALACTOMANNAN (ASPERGILLUS ANTIGEN), BRONCHOALVEOLAR LAVAGE, GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM, GALACTOSEMIA CLASSICAL (TRANSFERASE) QUANTITATIVE, BLOOD, GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG, GALACTOSEMIA (GALT) GENE MUTATION DETECTION, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IgG, GFR (GLOMERULAR FILTRATION RATE), ESTIMATED, GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL, GLUCOSE CHALLENGE TEST (GCT) PREGNANCY, 75g GLUCOSE, GLUCOSE FASTING (F) AND POST MEAL (PP), 2 HOURS, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY,100g GLUCOSE, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IFA, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY, 75g GLUCOSE, HISTOPATHOLOGY SPECIAL STAIN: PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH), HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE, HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE REAL TIME PCR, HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE, HISTOPATHOLOGY SPECIAL STAIN: VAN GIESONS, HCG BETA TOTAL QUANTITATIVE, 24 HOUR URINE, HCG BETA TOTAL QUANTITATIVE, RANDOM URINE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE REAL TIME PCR, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS, HOMA-IR; INSULIN RESISTANCE INDEX C-PEPTIDE MODEL, HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL QUALITATIVE, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IgG ANTIBODIES; DSA-SAB CLASS I & II, HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG, HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING QUALITATIVE PCR, HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST, HLA MIXED ANTIBODY SCREEN: PRA CLASS I, II & MICA, HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL IgG & IgM, SERUM, HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL IgG & IgM, SERUM, HEMOCHROMATOSIS DETECTION HFE GENOTYPING, HUMAN HERPESVIRUS 6 (HHV6) QUALITATIVE PCR, HUMAN HERPES VIRUS 7 (HHV7) QUALITATIVE PCR, HEMOPHILIA A, HEMOPHILIA B & VON WILLEBRAND DISEASE MUTATION DETECTION, HLA-CELIAC DISEASE: DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8, HLA DNA HIGH RESOLUTION TYPING- A, B, C, DR & DQ, HEPARIN INDUCED THROMBOCYTOPENIA (HIT); ANTI PLATELET FACTOR 4-HEPARIN (PF4-H), IgG QUANTITATIVE, HYPOTHYROIDISM / HASHIMOTO'S DISEASE PANEL, HLA DNA HIGH RESOLUTION TYPING: DQB1 LOCUS, H1N1 (SWINE FLU) QUALITATIVE REAL TIME PCR, HLA DNA HIGH RESOLUTION TYPING: DRB1 LOCUS, HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 10 ANTIGENS PCR, HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 6 ANTIGENS LUMINEX, HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT PCR, HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS), HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM, HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL, HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING TEST, HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE, HHH SYNDROME; HYPERORNITHINEMIA - HYPERAMMONEMIA - HOMOCITRULLINURIA SYNDROME, HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC) PHOTOMICROGRAPH, HISTO/CYTOPATHOLOGY SLIDE(S) / BLOCK(S) ISSUE, HISTO/CYTOPATHOLOGY, SLIDES (S) / BLOCKS (S) ISSUE, Hepatitis B Surface Antigen (Hbsag) Rapid Screening, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 6 TO 10 SLIDES, HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION, HISTO/ IHC/CYTO DIGITIZATION OF SLIDES, 11 TO 20 SLIDES, HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING, HISTO/ IHC DIGITIZATION OF SLIDES, UPTO 5 SLIDES, HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE ULTRA, HLA DSA (DONOR SPECIFIC IgG ANTIBODIES) CLASS I & II, HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR, HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN, HEPATITIS B VIRUS PCR QUALITATIVE; HBV DNA PCR QUALITATIVE, HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN, HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN, HLA HYPERSENSITIVITY TO ABACAVIR (B*57:01), HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58:01), HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15:02), HEPATITIS C VIRAL RNA PCR QUALITATIVE; HCV RNA PCR QUALITATIVE, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY PANEL, HLA-NARCOLEPSY: DRB1*15, DQB1*06:02, DQA1*01:02, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) KIDNEY BIOPSY, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE ULTRA, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS I QUANTITATIVE, Hepatitis C Virus (HCV) Rapid Screening Test, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgA, HLA-PANEL REACTIVE IgG ANTIBODIES (PRA) SCREEN, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgG, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPEINT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgM, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL1, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3, HEPATITIS G VIRUS (HGV) RNA DETECTION PCR, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4, HISTOPATHOLOGY KIDNEY: BIOPSY SECOND OPINION, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES; DSA-SAB CLASS I, HISTOPATHOLOGY SPECIAL STAIN: ACID FAST (Z N STAIN), HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES; DSA-SAB CLASS II, HISTOPATHOLOGY SPECIAL STAIN: ALCIAN BLUE, HCG BETA TOTAL QUANTITATIVE, TUMOR MARKER, HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL IgG & IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: COPPER (RHODANINE), HERPES SIMPLEX VIRUS (HSV) 1+2 IgM, SERUM, HISTOPATHOLOGY SPECIAL STAIN: FONTANA MASSON, HISTOPATHOLOGY SPECIAL STAIN: GOMORIS METHENAMINE SILVER, HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: IRON (PERLS STAIN), HERPES SIMPLEX VIRUS (HSV) TYPE 2 PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MASSON TRICHROME, HBDH; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE, HERPES SIMPLEX VIRUS (HSV) TYPE I PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: MUCICARMINE, HERPES SIMPLEX VIRUS (HSV) 1+2 IgG, SERUM, HISTOPATHOLOGY SPECIAL STAIN: PERIODIC ACID SCHIFF (PAS), HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN, HERPES VIRUS 6 (HHV-6) ANTIBODIES PANEL IgG & IgM, HISTOPATHOLOGY SPECIAL STAIN: AMYLOID (CONGO RED), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: DOUBLE NEGATIVE T CELLS (DNT), IMMUNOHISTOCHEMISTRY: COMPREHENSIVE PANEL, INS MYCOBACTERIUM TUBERCULOSIS FIRST & SECOND LINE DRUG RESISTANCE PROFILE, IMMUNOHISTOCHEMISTRY: CARBONIC ANHYDRASE-9 (CA-9), Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, IMMUNOHISTOCHEMISTRY: LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD16+56, IMMUNOHISTOCHEMISTRY: MYELOPEROXIDASE (MPO), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34 (STEM CELL) ENUMERATION, IMMUNOHISTOCHEMISTRY: NEUROFILAMENT POLYPEPTIDE, IMMUNOHISTOCHEMISTRY: NEURON SPECIFIC ENOLASE (NSE), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD103, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD10 (CALLA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD117, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD11c, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 1, IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD123, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 3, IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD13, IMMUNOHISTOCHEMISTRY: DIGITAL BREAST CANCER PANEL 4, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD138, IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD14, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD15, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD19, IMMUNOHISTOCHEMISTRY: GLUTAMINE SYNTHETASE, IMMUNOHISTOCHEMISTRY: SERUM ASSOCIATED AMYLOID (SAA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD1a, IMMUNOHISTOCHEMISTRY: GLYCOPHORIN A (GPA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD20, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD22, IMMUNOHISTOCHEMISTRY: TTF-1 (THYROID TRANSCRIPTION FACTOR-1), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD23, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD25, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD33, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD34, IMMUNOHISTOCHEMISTRY: LUTEINIZING HORMONE (LH), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD36, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD38, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD41a, IMMUNOHISTOCHEMISTRY: 34-BETA E12 / HMW-CK, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD45, IMMUNOHISTOCHEMISTRY: LMW-CK (LOW MOLECULAR WEIGHT CYTOKERATIN), IMMUNOHISTOCHEMISTRY: ACTIN (SMOOTH MUSCLE ACTIN), IMMUNOHISTOCHEMISTRY: LUNG NON-SMALL CELL CARCINOMA (NSCC) PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD61, IMMUNOHISTOCHEMISTRY: AFP (ALPHA FETO PROTEIN), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD64, IMUNOHISTOCHEMISTRY: MICROSATELLITE INSTABILITY PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79a, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD79b, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD MPO, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: FMC-7, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: GLYCOPHORIN, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: HLA DR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgG HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN CYTOPLASMIC, IMMUNOHISTOCHEMISTRY: NEUROENDOCRINE TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: IgM HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: KAPPA & LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: ZAP-70, IMMUNOHISTOCHEMISTRY: ESTROGEN RECEPTOR (ER), IMMUNOHISTOCHEMISTRY: BREAST CANCER PANEL 2, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: CD49d, IBD (INFLAMMATORY BOWEL DISEASE) SCREENING PANEL, IMMUNOHISTOCHEMISTRY: ISOCITRATE DEHYDROGENASE (IDH-1), IMMUNOHISTOCHEMISTRY PD-L1 SP263 (VENTANA), IMMUNOHISTOCHEMISTRY PDL1 SP142 (VENTANA), IgVH HYPERMUTATION ANALYSIS, CONFIRMATORY, INFLUENZA LIKE ILLNESS / ILI SARS-CoV-2 (COVID-19) PANEL, IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA, IMMUNOHISTOCHEMISTRY: CEA (CARCINOEMBRYONIC ANTIGEN), IMMUNOHISTOCHEMISTRY: HER-2 / ERBB2 BREAST, IMMUNOHISTOCHEMISTRY: CHROMOGRANIN-A (CGA), IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED, IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC, IMMUNOHISTOCHEMISTRY: CYTOMEGALOVIRUS (CMV), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 19 (CK-19), IMMUNOHISTOCHEMISTRY: CYTOKERATIN-20 (CK-20), IMMUNOHISTOCHEMISTRY: THROMBOSPONDIN (THSD7A), IMMUNOHISTOCHEMISTRY: CYTOKERATIN- 7 (CK-7), IMMUNOHISTOCHEMISTRY: THYROID CARCINOMA PANEL, IMMUNOHISTOCHEMISTRY: CYTOKERATIN (PANCYTOKERATIN), IMMUNOHISTOCHEMISTRY: THYROID STIMULATING HORMONE (TSH), IMMUNOHISTOCHEMISTRY: SINGLE MARKER WITHOUT IINTERPRETATION, IMMUNOFIXATION ELECTROPHORESIS (IFE), 24 HOUR URINE, IMMUNOHISTOCHEMISTRY: EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), IMMUNOHISTOCHEMISTRY: ANY 5 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: EPITHELIAL MEMBRANE ANTIGEN (EMA), IMMUNOHISTOCHEMISTRY: ANY 3 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY: FOLLICLE STIMULATING HORMONE (FSH), IMMUNOHISTOCHEMISTRY: GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP), IMMUNOHISTOCHEMISTRY: GROWTH HORMONE (GH), IMMUNOHISTOCHEMISTRY: HEPATOCYTE SPECIFIC ANTIGEN (HSA), INSULIN FASTING (F) & POST PRANDIAL (PP) PANEL, IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE, INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; IL-2R, INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING QUALITATIVE PCR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: OBSTETRIC PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LYMPHOMA DIAGNOSTIC PANEL, IMMUNOHISTOCHEMISTRY: BLADDER VS PROSTATE CARCINOMA PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY: GERM CELL TUMOR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS, IMMUNOHISTOCHEMISTRY, PITUITARY ADENOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA -T, B or MYELOID, IMMUNOHISTOCHEMISTRY, PROSTATE BENIGN VS MALIGNANT PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL-CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL- CLL/HCL/SLL BASIC, IMMUNOHISTOCHEMISTRY: ANDROGEN RECEPTOR (AR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA MONITORING PANEL-HAIRY CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-PLASMA CELL DYSCRASIAS, IMMUNOHISTOCHEMISTRY: HUMAN CHORIONIC GONADOTROPIN (HCG), IMMUNOHISTOCHEMISTRY: TRIPLE NEGATIVE BREAST CANCER (TNBC) PANEL, JAK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION, JAK 2 V617F, CALR & MPL MUTATION DETECTION PROFILE, JAPANESE ENCEPHALITIS VIRUS (JEV) DETECTION PCR, KETONE BODY (BETA HYDROXYBUTYRATE), SERUM, KIDNEY BIOSPY / ELECTRON MICROSCOPY, SLIDES / IMAGES ISSUE, KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL, LUNG CANCER 12 GENE PANEL WITH PDL1 - VENTANA SP263, LEUKEMIA GENETIC PROFILE: ANY 6 MARKERS PCR QUALITATIVE, LEISHMANIA (KALA AZAR) rK-39 ANTIBODY, SERUM, LUNG CANCER PANEL: 12 GENE WITH PDL1 - VENTANA SP142, LIPOPROTEIN FRACTIONATION, ULTRACENTRIFUGATION, LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES IgG & IgM, LYME DISEASE (BORRELIA BURGDORFERI) DNA QUALITATIVE REAL TIME PCR, LYME DISEASE (BORRELIA BURGDORFERI) IgG & IgM IMMUNOBLOT, LYME DISEASE (BORRELIA BURGDORFERI) IgG IMMUNOBLOT, LYMPHOCYTE SUBSET ENUMERATION (TBNK) FOR COVID SEVERITY ASSESSMENT, LIVER KIDNEY MICROSOMAL 1 (LKM 1) ANTIBODY EIA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IFA, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA, LEGIONELLA PNEUMOPHILA IgG ANTIBODY, SERUM, LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION, LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION, LEPTOSPIRA ANTIBODIES PANEL IgG & IgM, EIA, LEUCOCYTE ADHESION DEFICIENCY (LAD I & II), Lp-PLA2 (LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2) ACTIVITY, LERGY SPECIFIC IgG: ASPERGILLUS FUMIGATUS, MYCOPLASMA PNEUMONIAE IgG & IgM ANTIBODIES PANEL, SERUM, MITOCHONDRIAL ANTIBODY (AMA) IFA IN DILUTIONS, MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES) MUTATION DETECTION, MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE, MYELIN ASSOCIATED GLYCOPROTEIN (MAG) IgM, METACHROMATIC LEUCODYSTROPHY QUANTITATIVE, BLOOD, MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA, MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS, MYELIN ASSOCIATED GLYCOPROTEIN- SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY (MAG-SGPG) IgM, METANEPHRINES FRACTIONATED, 24 HOUR URINE, METANEPHRINES FRACTIONATED, RANDOM URINE, MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR B-CLL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR MULTIPLE MYELOMA, MICM (MATERNALLY INHERITED CARDIOMYOPATHY) MUTATION DETECTION, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION, MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE, MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT, MITOCHONDRIAL SEQUENCING: WHOLE MITOCHONDRIAL GENOME SEQUENCING, MICROALBUMIN / ALBUMIN CREATININE RATIO, URINE, MATERNAL SERUM SCREEN 2: ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA (MBFD)/NIPT CHROMOSOME 21, MIXING STUDIES: APTT WITH PROTHROMBIN TIME STUDIES, MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC, MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY) MUTATION DETECTION, MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) PANEL, MUMPS VIRUS ANTIBODIES PANEL IgG & IgM, SERUM, MEASLES (RUBEOLA) ANTIBODIES PANEL IgG & IgM, SERUM, MPL (MYELOPROLIFERATIVE LEUKEMIA) GENE MUTATION, MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR, MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE, MUCOPOLYSACCHARIDOSIS (MPS) TYPE 1 (HURLER) QUANTITATIVE, BLOOD, MEDULLARY THYROID CARCINOMA MUTATION DETECTION, MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY) QUANTITATIVE, BLOOD, MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; VAN DER KNAAP AND NALBAND MLC GENE HOTSPOT MUTATION, MUCOPOLYSACCHARIDOSIS (MPS) TYPING, 24 HOUR URINE, MEMBRANOUS GLOMERULOPATHY (MGN): TARGET 5 ANTIGENS PANEL, MEMBRANOUS GLOMERULOPATHY (MGN) PLA2R NEGATIVE : TARGET 4 ANTIGENS PANEL, MYCOBACTERIUM TUBERCULOSIS PCR; MYCOSURE; TB PCR, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS, MYCOBACTERIUM TUBERCULOSIS rRNA DETECTION, TMA, NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE, Nx GEN SEQUENCING: HEREDITARY RETINOBLASTOMA, Nx GEN SEQUENCING: LEBER CONGENITAL AMAUROSIS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ULTRA, Nx GEN SEQUENCING: MEGALOENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, Nx GEN SEQUENCING: MICROPHTHALMIA / ANOPHTHALMIA / COLOBOMA SPECTRUM, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ADVANCED, NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR, NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR, NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE), NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE, Nx GEN SEQUENCING: BETHLEM MYOPATHY, MYOFIBRILLAR MYOPATHY & ULLRICH MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: CHARCOT-MARIE-TOOTH DISEASE & SENSORY NEUROPATHIES, Nx GEN CLINICAL EXOME SEQUENCING, ILLUMINA, Nx GEN SEQUENCING: DRAVET'S SYNDROME & EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY, Nx GEN SEQUENCING: DUCHENNE & BECKER MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: MATURITY ONSET DIABETES OF YOUNG (MODY), Nx GEN SEQUENCING: TUBEROUS SCLEROSIS COMPLEX, Nx GEN SEQUENCING: AICARDI-GOUTIERES SYNDROME, Nx GEN SEQUENCING: AMYOTROPHIC LATERAL SCLEROSIS, NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN), URINE, Nx GEN SEQUENCING: FAMILIAL HEMIPLEGIC MIGRAINE, Nx GEN SEQUENCING: COMPREHENSIVE EPILEPSY, OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST, ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL, ONCOMINE CHRONIC MYELOID LEUKAEMIA (CML) PANEL, ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL, ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) PANEL, ONCOMINE MYELODYSPLASTIC SYNDROME(MDS) PANEL, ONCOMINE MYELOPROLIFERATIVE NEOPLASM (MPN) PANEL, ONCOPRO COMPREHENSIVE CANCER PANEL: 161 GENES, OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL, ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS, P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE) TOTAL, PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1), PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING, PRIMARY IMMUNE DEFICIENCY SCREENING PANEL (PIDOT), PAN FUNGAL DETECTION AND IDENTIFICTION, PCR, PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A), PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE PCR, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE PCR, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) CONFIRMATORY TEST, PARTIAL THROMBOPLASTIN TIME ACTIVATED; PTT; APTT, PROSTATE TRUS BIOPSY AI PANEL REFLEX TO IMMUNOHISTOCHEMISTRY, PARVOVIRUS B19 ANTIBODIES PANEL IgG & IgM, PORPHYRINS TOTAL QUALITATIVE, RANDOM URINE, PORPHYRINS TOTAL QUANTITATIVE, 24- HOUR URINE, PROTEIN ELECTROPHORESIS & IMMUNOTYPING, SERUM, PRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR, PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL, PHOSPHATIDYLSERINE ANTIBODIES PANEL IgG & IgM, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUANTITATIVE, PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR, PTHrP; PARATHYROID HORMONE RELATED PROTEIN, PORPHOBILINOGEN (PBG) QUANTITATIVE, 24 HOUR URINE, PURKINJE CELL (Yo) ANTIBODY SCREEN, WITH REFLEX TO TITER AND WESTERN BLOT, CSF, PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN) ANTIBODY, PURKINJE CELL CYTOPLASMIC ANTIBODY TYPE Tr (DNER), PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, PIIINP (PROCOLLAGEN TYPE III AMINO TERMINAL PROPEPTIDE), Q FEVER (COXIELLA BURNETTI) ANTIBODIES IgG & IgM, QuantiFERON-TB Gold (QFT), INTERFERON GAMMA RELEASE ASSAY (IGRA), QuantiFERON-TB GOLD PLUS (QFT-PLUS), INTERFERON GAMMA RELEASE ASSAY (IGRA), ROCKY MOUNTAIN SPOTTED FEVER ANTIBODIES, ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM, RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL, RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL IgG & IgM, RS-CSARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY QUANTITATIVE, RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, BASIC, SARS-CoV-2 COVID-19 BIOMARKERS PANEL, EXTENDED, SARS-CoV-2 (COVID-19) NEUTRALIZING ANTIBODY, Swasthfit Advance Health Checkup - Full Body Checkup, SARS-COV-2 (COVID-19) RESPIRATORY COMPREHENSIVE PANEL, SCA-11 (SPINOCEREBELLAR ATAXIA): TTBK2 GENE MUTATION, SCA-12 (SPINOCEREBELLAR ATAXIA): PPP2R2B GENE MUTATION, SCA-17 (SPINOCEREBELLAR ATAXIA): TBP GENE MUTATION, SWASTHFIT COMPLETE PACKAGE WITH FREE WELLNESS REPORT, SCA-1 (SPINOCEREBELLAR ATAXIA): ATXN1 GENE MUTATION, SOLUBLE TRANSFERRIN RECEPTOR (sTfR), SERUM, Swasthfit Heart Check - Advance Health Checkup, SCA-2 (SPINOCEREBELLAR ATAXIA): ATXN2 GENE MUTATION, SCA-3 (SPINOCEREBELLAR ATAXIA): ATXN3 GENE MUTATION, SCA-5 (SPINOCEREBELLAR ATAXIA): SPTBN2 GENE MUTATION, SCA-6 (SPINOCEREBELLAR ATAXIA): CACNA1A GENE MUTATION, SPERM DNA FRAGMENTATION FLUORESCENT MICROSCOPY, SCA-7 (SPINOCEREBELLAR ATAXIA): ATXN7 GENE MUTATION, SCA-8 (SPINOCEREBELLAR ATAXIA): ATXN8OS & ATXN8 GENE MUTATION, Swasthfit Pro 3 (With Free Doctor Consultation), SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE, SPINAL MUSCULAR ATROPHY (SMA) CARRIER DETECTION, SPINAL MUSCULAR ATROPHY (SMA) MUTATION DETECTION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODIES PANEL IgG & IgM, SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS, SCA-23 (SPINOCEREBELLAR ATAXIA): PDYN GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, EIA, SCA-14 (SPINOCEREBELLAR ATAXIA): PRKCG GENE MUTATION, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgG, RAPID ASSAY, SCRUB TYPHUS (TSUTSUGAMUSHI) ANTIBODY IgM, EIA, Swasthfit Total - Heart Check - Full Body Checkup, Swasthfit Total - Iron Check - Full Body Checkup, STEROID PANEL: 21- HYDROXYLASE DEFICIENCY, STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH), STEROID PANEL FOR PCOS / NON-CLASSICAL CAH DIFFERENTIATION, STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS), SICKLE CELL ANEMIA TRIO PRENATAL MUTATION DETECTION, STOOL EXAMINATION HANGING DROP PREPARATION, STOOL EXAMINATION pH & REDUCING SUBSTANCES, STREPTOCOCCUS GROUP B ANTIGEN DETECTION, SARS-CoV-2 (COVID-19) ANTI-SPIKE IgG ANTIBODY PLUS, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA, SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA IN DILUTIONS, Swasthfit Tax Saver Basic Health Checkup - Full Body Checkup, SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR, Swasthfit Tax Saver Advance Health Checkup - Full Body Checkup, SMOOTH MUSCLE ANTIBODY (ASMA) IFA IN DILUTIONS, SCA (SPINOCEREBELLAR ATAXIA: EXTENDED PROFILE, TOTAL WBC COUNT & DIFFERENTAL COUNT & ESR, THALASSEMIA BETA TRIO PRENATAL MUTATION DETECTION, TB LAMP (LOOP MEDIATED ISOTHERMA AMPLIFICATION) QUALITATIVE DNA PCR, MYCOBACTERIUM TUBERCULOSIS COMPLEX, TB PLATINUM INTERFERON GAMMA RELEASE ASSAY (IGRA), TOXOPLASMA ANTIBODIES PANEL IgG & IgM, SERUM, TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION, TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING, TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, CORD BLOOD, TSI; THYROID STIMULATING IMMUNOGLOBULIN, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgA, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgG, TYPHUS FEVER (RICKETTSIA) ANTIBODIES IgG & IgM, TESTOSTERONE FREE & SEX HORMONE BINDING GLOBULIN, THALASSEMIA ALPHA TRIO PRENATAL MUTATION DETECTION, t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE, t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE, t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE, t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE, t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE, URINE EXAMINATION ROUTINE; URINE R/E AUTOMATED, UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE 'TA' REPEATS) DETECTION, VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD, VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) SCREENING, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, CSF, VITAMIN B12 BINDING CAPACITY UNSATURATED; TRANSCOBALAMIN, VARICELLA ZOSTER VIRUS (VZV) QUALITATIVE PCR, VMA (VANILLYL MANDELIC ACID), 24 HOUR URINE, VMA (VANILLYL MANDELIC ACID), RANDOM URINE, VON WILLEBRAND FACTOR COLLAGEN BINDING ACTIVITY (vWF:CB), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM, VON WILLEBRAND FACTOR RISTOCETIN COFACTOR ACTIVITY (vWF:RCo), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, CSF, VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL IgG & IgM, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, SERUM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgM, SERUM, von WILLEBRAND FACTOR ANTIGEN; vWF Ag, Y-CHROMOSOME MICRODELETION DETECTION , PCR, YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING.